Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 46, Issue 5, Pages 1190-1198Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.46.5.1190-1198.2002
Keywords
-
Categories
Funding
- NIGMS NIH HHS [GM60761] Funding Source: Medline
Ask authors/readers for more resources
To determine whether the widespread clinical use of -lactams has been selective for Citrobacter freundiiderived alleles of plasmid ampC genes, we generated a Bayesian consensus phylogeny of the published ampC sequences and compared the MICs of 16 -lactam antibiotics for Escherichia coli strains containing cloned copies of the C.freundii ampC alleles. We found that for the majority of compounds investigated, there has been essentially no increase in beta-lactam resistance conferred by those alleles. We also found that ampC alleles from the chromosomes of two beta-lactam-sensitive C.freundii strains isolated in the 1920s, before the clinical use of antibiotics, were as effective at providing beta-lactam resistance in E. coli as were the plasmid-borne alleles from beta-lactam-resistant clinical isolates. These results suggest that selection for increased resistance to beta-lactam antibiotics has not been a significant force directing the evolution of the C.freundii ampC alleles found in beta-lactam-resistant clinical isolates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available